Patents by Inventor Robert BRUCKER

Robert BRUCKER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with fungi and other pathogenic microbes
    Patent number: 12708649
    Abstract: Among other things, disclosed herein are compositions and methods for using human-isolated or synthetic Alcaligenes faecalis, Bacillus altitudinis, Bacillus pumilus, Bacillus subtilis, or Janthinobacterium lividum. Compositions may improve skin health. Methods may include applying human-isolated or synthetic Alcaligenes faecalis, Bacillus altitudinis, Bacillus pumilus, Bacillus subtilis, or Janthinobacterium lividum over a host or host area, such as skin or mucosa to minimize the presence of one or more pathogenic microbes, maximize therapeutic effects of one or more additional therapeutics, and/or improve health of a host or host area.
    Type: Grant
    Filed: October 13, 2021
    Date of Patent: August 18, 2026
    Assignee: DermBiont, Inc.
    Inventors: Robert Brucker, Yanjun Huang, Nikola Jovanovic, Bhanu Prakash Chowdary Sakhamuri, Ida Lister, Xuecheng Zhang, Sanjay Jain, Emma Jean Mildred Taylor
  • COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH FUNGI AND OTHER PATHOGENIC MICROBES
    Publication number: 20240269198
    Abstract: Among other things, disclosed herein are compositions and methods for using human-isolated or synthetic Alcaligenes faecalis, Bacillus altitudinis, Bacillus pumilus, Bacillus subtilis, or Janthinobacterium lividum. Compositions may improve skin health. Methods may include applying human-isolated or synthetic Alcaligenes faecalis, Bacillus altitudinis, Bacillus pumilus, Bacillus subtilis, or Janthinobacterium lividum over a host or host area, such as skin or mucosa to minimize the presence of one or more pathogenic microbes, maximize therapeutic effects of one or more additional therapeutics, and/or improve health of a host or host area. A method to minimize a pathogenic microbe may include applying to a surface a composition including human-isolated or synthetic Alcaligenes faecalis, Bacillus altitudinis, Bacillus pumilus, Bacillus subtilis, or Janthinobacterium lividum and an acceptable carrier. Compositions and methods may include a prebiotic or another microbe to maximize growth and/or metabolites (e.g.
    Type: Application
    Filed: October 13, 2021
    Publication date: August 15, 2024
    Inventors: Robert BRUCKER, Yanjun HUANG, Nikola JOVANOVIC, Bhanu Prakash Chowdary SAKHAMURI, Ida LISTER, Xuecheng ZHANG, Sanjay JAIN, Emma Jean Mildred TAYLOR